Legislation

This hearing is focused on discussing the implementation of the CARE Court, which aims to provide support for individuals with mental health and substance use issues by October 1, 2023. It will involve presentations from the Department of Public Health, Superior Court, and Department of Homelessness and Supportive Housing.

Hearing on plans to implement the Community Assistance, Recovery, and Empowerment (CARE) Court by October 1, 2023; and requesting the Department of Public Health, Superior Court, and Department of Homelessness and Supportive Housing to present.

This ordinance requires all retail pharmacies in San Francisco to keep at least two boxes of an opioid antagonist, like naloxone, on their shelves to help reverse opioid overdoses. The goal is to improve access to life-saving medication in the community.

Ordinance amending the Health Code to require each retail pharmacy in the City to stock at least two boxes of an opioid antagonist, such as naloxone, used to reverse opioid overdoses.

This resolution urges the San Francisco Department of Public Health to develop a program that offers resources and education to gun violence victims about their legal rights to sue gun manufacturers under California Assembly Bill No. 1594. It has been passed by the city legislature.

Resolution urging the San Francisco Department of Public Health to create a program to provide resources and education for victims of gun violence regarding their rights to file lawsuits against gun manufacturers in accordance to California State Assembly Bill No. 1594.

This legislation calls for a hearing to discuss a report on accidental overdose deaths and the responses from various city departments. It requests updates from the Office of the Chief Medical Examiner, Department of Public Health, Department of Homelessness and Supportive Housing, Police Department, and Office of the District Attorney.

Hearing on the Office of the Chief Medical Examiner's report on Accidental Overdose Deaths, issued on January 18, 2023, and departmental responses to accidental overdose deaths; and requesting the Office of Chief Medical Examiner, Department of Public Health, Department of Homelessness and Supportive Housing, Police Department, and Office of the District Attorney to report.

This resolution allows the Department of Public Health to accept and use an additional $28,327 grant from the National Institutes of Health for a drug abuse treatment program, increasing the total funding to $109,937 for the period from June 1, 2020, to February 29, 2024. The funding will support participation in a clinical trials network focused on drug treatment.

Resolution retroactively authorizing the Department of Public Health to accept and expend a grant increase from the National Institutes of Health through Oregon Health & Science University for participation in a program, entitled “Western States Node of the National Drug Abuse Treatment Clinical Trials Network,” in the amount of $28,327 for the period of March 1, 2023, through February 29, 2024, for a total grant award amount of $109,937 for the total period of June 1, 2020, through February 29, 2024.

This resolution approves an increase in funding and an extension of the contract between Maitri AIDS Hospice and the Department of Public Health to provide hospice services for residents of San Francisco. The total agreement will now be $14,130,444 and will run through March 31, 2027.

Resolution approving Amendment No. 3 to the agreement between Maitri AIDS Hospice and the Department of Public Health (DPH), to provide hospice services for chronically impaired residents of San Francisco, to increase the agreement by $4,594,103 for an amount not to exceed $14,130,444; to extend the term by four years from March 31, 2024, for a total agreement term of July 1, 2017, through March 31, 2027; and to authorize DPH to enter into amendments or modifications to the contract prior to its final execution by all parties that do not materially increase the obligations or liabilities to the City and are necessary to effectuate the purposes of the contract or this Resolution.

This legislation schedules a public hearing for the Board of Supervisors to discuss Laguna Honda Hospital's plan for recertification and the process for transferring and relocating patients. The Department of Public Health will present information during this hearing, which is set for September 26, 2023.

Hearing of the Board of Supervisors sitting as a Committee of the Whole on Tuesday, September 26, 2023, at 3:00 p.m., to hold a public hearing on Laguna Honda Hospital’s Strategy for Recertification and the Submission of a Closure and Patient Transfer and Relocation Plan; and requesting the Department of Public Health to present; scheduled pursuant to Motion No. M23-010 (File No. 230034), approved on January 24, 2023.

This resolution approves a lease agreement for property at 716-720 Sacramento Street, allowing the Department of Public Health to pay $370,000 annually with 3% increases, effective from July 1, 2023, until June 30, 2026, with options to extend. It also gives the Director of Property the authority to make minor changes to the lease as needed without increasing the city's obligations.

Resolution retroactively approving and authorizing the Director of Property, on behalf of the Department of Public Health, to execute a Fourth Amendment to a Lease of real property located at 716-720 Sacramento Street, with 716 Sacramento LLC (73.4%) and DLS Sacramento LLC (26.6%), at a base rent of $370,000 per year with 3% annual increases, for an initial term commencing July 1, 2023, with a total term of December 1, 1996, through June 30, 2026, with two one-year options to extend; and to authorize the Director or Property to enter into any extensions, amendments, or modifications to the Lease that do not materially increase the obligations or liabilities to the City and are necessary to effectuate the purposes of the Lease or this Resolution.

This resolution approves a five-year lease agreement for office space at Bayview Plaza for the Department of Public Health, with an annual base rent of $554,347 and 3% yearly increases. It also authorizes the Director of Property to make necessary amendments or extensions to the lease without significantly altering the city's obligations or benefits.

Resolution approving and authorizing the Director of Property, on behalf of the Department of Public Health, to execute a Lease Agreement for the term of five years with two five-year options to extend the term for continued use of office space with the Bayview Plaza, LLC, located at 3801-3rd Street, Suite 400, at a base rent of $554,347 per year (approximately $37.39 per square foot) with 3% annual rent increases effective upon approval of the Resolution and upon execution of the Lease by the Director of Property; and authorizing the Director of Property to execute any amendments, options to extend the agreement term, make certain modifications and take certain actions that do not materially increase the obligations or liabilities to the City, do not materially decrease the benefits to the City and are necessary or advisable to effectuate the purposes of the Lease Agreement or this Resolution.

The ordinance authorizes a payment of $211,129.46 to Build Group, Inc. to settle a lawsuit regarding a breach of contract related to the renovation of the Maxine Hall Health Center, with Build Group waiving any further claims related to the project. This settlement resolves a cross-complaint filed against the City in November 2022.

Ordinance authorizing settlement of the cross-complaint filed by Build Group, Inc. against the City and County of San Francisco for a payment to Build Group, Inc. of $211,129.46; the cross-complaint was filed on November 22, 2022, in the Superior Court of the State of California, County of San Francisco, Case No. CGC-22-598717; entitled CPM Environmental, Inc. v. Build Group, Inc. and DOES 1-100, et al.; the lawsuit involves allegations of breach of contract relating to the renovation of the Maxine Hall Health Center; other material terms of the settlement are that Build Group, Inc. waives all other claims it has or may have relating to the project.

The ordinance authorizes the City and County of San Francisco to settle a lawsuit for $100,000 related to alleged medical negligence filed by Breon Johnson. This lawsuit was initiated on September 26, 2022, in San Francisco Superior Court.

Ordinance authorizing settlement of the lawsuit filed by Breon Johnson against the City and County of San Francisco for $100,000; the lawsuit was filed on September 26, 2022, in San Francisco Superior Court, Case No. CGC-22-601937; entitled Breon Johnson v. The Regents of The University of California, et al.; the lawsuit involves alleged medical negligence.

This resolution approves an emergency declaration for repair work at Laguna Honda Hospital, allowing the city to spend up to $28.4 million for necessary repairs. The work is deemed urgent and exceeds the typical spending limit for such projects.

Resolution approving the Director of Public Works’ declaration of emergency under Administrative Code, Section 6.60, for repair work at Laguna Honda Hospital and Rehabilitation Center, located at 375 Laguna Honda Boulevard, estimated to cost in excess of $250,000 but not to exceed $28,400,000.

This resolution officially designates August 31, 2023, as International Overdose Awareness Day in San Francisco. It aims to raise awareness about overdose prevention and honor those affected by overdose.

Resolution recognizing August 31, 2023, as an International Overdose Awareness Day in the City and County of San Francisco.

This resolution approves a two-year extension of a lease for offices occupied by the U.S. Drug Enforcement Administration at San Francisco International Airport, increasing the annual rent to $620,611.20. The lease term will now run from October 1, 2015, through September 30, 2025.

Resolution approving Modification No. 2 of Lease No. GS-09P-LCA03384 between the United States (U.S.) Government and the City and County of San Francisco, acting by and through its Airport Commission, to extend the term by two years from October 1, 2023, for a total term of October 1, 2015, through September 30, 2025, and increase the annual rent to $620,611.20 for offices occupied by the U.S. Drug Enforcement Administration.

This resolution approves an amendment to the agreement with Mission Neighborhood Health Center to provide HIV health services, increasing funding by over $6.6 million and extending the agreement's term by six years. It also allows the Department of Public Health to make minor modifications to the agreement as needed.

Resolution approving Amendment No. 1 to the Agreement between Mission Neighborhood Health Center and the Department of Public Health, to provide HIV health services, to increase the agreement by $6,624,852 for an amount not to exceed $11,300,310; to extend the term by six years from February 29, 2024, for a total agreement term of March 1, 2020, through February 28, 2030; and to authorize DPH to enter into modifications of the Agreement that do not materially increase the City’s obligations or liabilities and are necessary to effectuate the purposes of the Agreement or this Resolution.

This resolution allows the Department of Public Health to use a cash gift of up to $79,231.32 from the Estate of Janet D. Kramer for Laguna Honda Hospital, covering the period from July 1, 2022, to June 30, 2032. It has been officially approved and is now in effect.

Resolution retroactively authorizing the Department of Public Health to accept and expend a cash gift in the amount of up to $79,231.32 from the Estate of Janet D. Kramer through the Federal Reserve in support of the Laguna Honda Hospital for the period of July 1, 2022, through June 30, 2032.

This motion appoints Norlissa Cooper to the San Francisco Health Authority, with her term ending on January 15, 2024. The motion has been passed.

Motion appointing Norlissa Cooper, term ending January 15, 2024, to the San Francisco Health Authority.

This hearing will evaluate the Controller's Annual Performance Report and its effects on the city budget, while also assessing how various departments are achieving their performance goals. Several city departments, including the Fire Department and Police Department, will be asked to provide updates during this hearing.

Hearing to consider the Controller’s Annual Performance Report and its impact on the budget and to hear how departments are meeting their performance goals; and requesting the Controller’s Office, Fire Department, Public Works, Department of Homelessness and Supportive Housing, Department of Emergency Management, Human Services Agency, Recreation and Park Department, Department of Public Health, Library, Police Department, and City Administrator to report.

This legislation calls for a hearing to address the staffing shortages at San Francisco General Hospital. It requests reports from the hospital and relevant city departments on the issue.

Hearing on the ongoing staffing shortages at San Francisco General Hospital; and requesting San Francisco General Hospital, the Department of Public Health, and Department of Human Resources to report.

The ordinance authorizes a settlement of $229,610,002 from Walgreen Co. related to their improper dispensing of prescription opioids, which contributed to the opioid crisis in San Francisco. The City will receive $200,000,002 over 15 years, while outside counsel will be paid $29,610,000.

Ordinance authorizing settlement of the lawsuit filed by the City and County of San Francisco and the People of the State of California against Walgreen Co. for $229,610,002 (the City to be paid $200,000,002 over 15 years, the City’s outside counsel to be paid $29,610,000); the lawsuit was filed on December 18, 2018, in the United States District Court for the Northern District of California, Case No. 3:18-cv-7591-CRB-JSC; entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc f/k/a Actavis Plc, Watson Pharmaceuticals, Inc. n/k/a Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. f/k/a Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; the lawsuit involves Walgreen Co.’s improper and unlawful dispensing of prescription opioids at its pharmacies, which contributed to the epidemic of opioid abuse and misuse and caused a public nuisance in San Francisco.

The ordinance authorizes a settlement of nearly $25 million from several pharmaceutical companies for their role in misleadingly marketing opioids and contributing to the opioid crisis in San Francisco. It allocates funds for the City Attorney's Office and includes naloxone valued at $20 million to help combat opioid overdoses.

Ordinance authorizing settlement of the lawsuit filed by the City and County of San Francisco and the People of the State of California against Cephalon, Inc.; Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd; Watson Laboratories, Inc.; Actavis LLC; Actavis Pharma, Inc. (f/k/a Watson Pharma, Inc.); Actavis Elizabeth LLC; Actavis Mid Atlantic LLC; Warner Chilcott Company, LLC; Actavis South Atlantic LLC; Actavis Totowa LLC; Actavis Kadian LLC; Actavis Laboratories UT, Inc. (f/k/a/ Watson Laboratories, Inc.-Salt Lake City); Actavis Laboratories FL, Inc. (f/k/a Watson Laboratories, Inc.-Florida); and Anda, Inc. for $24,797,604 (the City to be paid $19,499,928 over 13 years, the City’s outside counsel to be paid $3,043,340, and the City Attorney’s Office to be paid $2,254,336) and naloxone valued at $20,000,000; directing the Controller to allocate funds to the City Attorney’s Office as provided in the settlement agreement; the lawsuit was filed on December 18, 2018, in the United States District Court for the Northern District of California, Case No. 3:18-cv-7591-CRB-JSC; entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc f/k/a Actavis Plc, Watson Pharmaceuticals, Inc. n/k/a Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. f/k/a Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; the lawsuit involves allegations that the Teva defendants created a public nuisance and violated the Unfair Competition Law by falsely and misleadingly marketing opioids as safer than they actually are and distributing increasingly large volumes of opioids in and around San Francisco despite knowledge of the growing epidemic caused by opioid misuse, and by failing to prevent and report suspicious opioid orders as required by state and federal law.

The ordinance authorizes a settlement of nearly $12.9 million from Allergan related to a lawsuit over misleading opioid marketing and distribution practices that contributed to the opioid crisis in San Francisco. The settlement allocates funds for the City, outside counsel, and the City Attorney's Office over a five-year period.

Ordinance authorizing settlement of the lawsuit filed by the City and County of San Francisco and the People of the State of California against Allergan Finance, LLC (f/k/a Actavis, Inc., which, in turn, was f/k/a Watson Pharmaceuticals, Inc.) and Allergan Limited (f/k/a Allergan plc, which, in turn, was f/k/a Actavis plc) for $12,916,274 (the City to be paid $10,156,889 over 5 years, the City’s outside counsel to be paid $1,585,179, and the City Attorney’s Office to be paid $1,174,206); directing the Controller to allocate funds to the City Attorney’s Office as provided in the settlement agreement; the lawsuit was filed on December 18, 2018, in the United States District Court for the Northern District of California, Case No. 3:18-cv-7591-CRB-JSC; entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc f/k/a Actavis Plc, Watson Pharmaceuticals, Inc. n/k/a Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. f/k/a Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; the lawsuit involves allegations that the Allergan defendants created a public nuisance and violated the Unfair Competition Law by falsely and misleadingly marketing opioids as safer than they actually are and distributing increasingly large volumes of opioids in and around San Francisco despite knowledge of the growing epidemic caused by opioid misuse, and by failing to prevent and report suspicious opioid orders as required by state and federal law.

This resolution allows the Department of Public Health to use a $100,000 grant for a program aimed at improving behavioral health integration from July 1, 2023, to January 31, 2027. It has been officially approved and is now in effect.

Resolution retroactively authorizing the Department of Public Health to accept and expend a grant in the amount of $100,000 from the Purchaser Business Group on Health for participation in a program, entitled “CalHIVE Behavioral Health Integration (BHI) Improvement Collaborative,” for the period of July 1, 2023, through January 31, 2027.

This resolution approves an increase of $1.7 million to an existing contract with Dignity Health for the management and operation of the SFO Medical Clinic, raising the total contract amount to $12.7 million. The contract term remains unchanged, running from July 1, 2019, to June 30, 2024.

Resolution approving Modification No. 4 to Contract No. 50118.02 with Dignity Health dba St. Mary’s Medical Center for Management and Operation of the SFO Medical Clinic to increase the contract amount by $1,700,000 for a new contract amount not to exceed $12,700,000 pursuant to Charter, Section 9.118(b), with no change to the contract term of July 1, 2019, through June 30, 2024, effective upon approval of this Resolution.

The resolution supports Governor Gavin Newsom's proposal to modernize California's behavioral healthcare system, which includes updating the Mental Health Services Act and a $4.68 billion bond to create at least 10,000 new behavioral health beds. It has passed and aims to improve mental health services across the state.

Resolution supporting Governor Gavin Newsom’s 2024 ballot initiative proposal to modernize California’s behavioral healthcare system, which includes California State Senate Bill No. 326, an update of the Mental Health Services Act authored by Senator Susan Talamantes Eggman, and California State Assembly Bill No. 531, a bill authored by Jacqui Irwin that would place before the voters a $4.68 billion General Obligation Bond intended to build at least 10,000 new behavioral health beds across California community treatment campuses and facilities.